USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Pathfinder Enterprises
Address:
2402 N.w. 66th Court
Gainesville, FL 32606
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $103,285.00 2
SBIR Phase II $360,906.00 1

Award List:

CO2 ANGIOGRAPHY INJECTOR DEVELOPMENT

Award Year / Program / Phase:
1983 / SBIR / Phase I
Award Amount:
$54,285.00
Agency:
HHS
Principal Investigator:
Richard E. Sowls
Abstract:
N/a

CO2 ANGIOGRAPHY INJECTOR DEVELOPMENT

Award Year / Program / Phase:
1984 / SBIR / Phase II
Award Amount:
$360,906.00
Agency:
HHS
Principal Investigator:
Richard E. Sowls
Abstract:
Angiography with standard contrast media is often painful and occasionally causes hypersensitivity (allergic) reactions in patients. digital subtraction x-ray techniqueshave made possible the use of the gas co2 as a contrast agent for arterial and venous imaging. no co2 injectors produced for this… More

ELIMINATION OF EMBOLI FROM VESSELS IN THE BODY WILL BE MADE EASY AND SAFE BY THE USE OF A PERCUTANEOUS MECHANICAL SPIRALEMBOLUS REMOVAL DEVICE.

Award Year / Program / Phase:
1986 / SBIR / Phase I
Award Amount:
$49,000.00
Agency:
HHS
Principal Investigator:
Robert j hirko , PRINCIPAL INVESTIGATOR
Abstract:
Elimination of emboli from vessels in the body will be made easy and safe by the use of a percutaneous mechanical spiralembolus removal device. this device has been shown to be feasible and will undergo engineering improvements to yield a unit ready for clinical trials. in vitro evaluation of its… More